潜伏期、抗菌药物耐药模式与细菌感染相关肾小球肾炎
该研究纳入南印度单中心501例细菌感染相关肾小球肾炎成人患者,按潜伏期分为副感染、围感染和感染后三型,分析病原菌、耐药模式及肾脏预后。中位随访显示15%进展至肾衰竭,4%死亡;副感染型、eGFR<30、中重度间质纤维化/肾小管萎缩及未用RAS阻滞剂是肾衰竭的显著危险因素。
要点
- 副感染型肾小球肾炎多由非链球菌及耐药菌引起,肾脏预后较差。
- 耐药菌感染(MRSA、ESBL、碳青霉烯耐药)主要见于副感染型。
- eGFR<30、中重度IFTA及未用RAS阻滞剂亦为肾衰竭危险因素。
核心结论
- 副感染型肾小球肾炎主要由非链球菌和耐药细菌感染引起,与不良肾脏预后相关。
研究设计与样本
- 单中心活检登记研究,纳入2005-2017年501例连续成人细菌感染相关肾小球肾炎患者,随访至2019年12月。
- 潜伏期定义为感染消退至肾小球肾炎发病的时间,分为副感染、围感染和感染后三型。
主要发现
- 最常见致病菌为化脓性链球菌(137/353,39%)。
- 耐药非链球菌中,耐甲氧西林金黄色葡萄球菌占25%(4/16),产超广谱β-内酰胺酶占20%(12/59),碳青霉烯耐药菌占10%(6/59)。
- 22株耐药菌中20株(91%)分离自副感染组。
- 321例随访>3个月患者中,48例(15%)在中位10(2-37)个月进展至肾衰竭,14例(4%)死亡。
- Cox模型显示副感染型、eGFR<30 ml/min per 1.73 m2、中重度间质纤维化及肾小管萎缩、未用RAS阻滞剂是肾衰竭的显著危险因素。
临床怎么用
- 对细菌感染相关肾小球肾炎应结合潜伏期分型评估肾脏预后。
- 副感染型患者需警惕耐药菌感染,并积极考虑RAS阻滞剂治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Bacterial infection-related GN occurs concurrent to or after known or unknown infections. It is important to understand the clinical implications of the bacterial isolates, antimicrobial resistance patterns, and effect of latency-based classification on kidney and patient outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 501 consecutive adults diagnosed with bacterial infection-related GN between 2005 and 2017 were included from a biopsy registry of 15,545 patients at a single center in South India, and follow-up data were collected from electronic medical records until December 2019. Latency was defined as time between resolution of infection and onset of GN, which was classified as parainfectious, peri-infectious, or postinfectious GN. Longitudinal kidney and patient outcomes were studied. RESULTS: The mean age of the cohort was 40 (± 15) years, 6% were above 65 years, and 330 (66%) were men. Diabetes was present in 93 (19%) patients. Seventy percent (353 of 501) of patients had known infections, with the median latent period for parainfectious (115 of 353, 33%), peri-infectious (97 of 353, 27%), and postinfectious (141 of 353, 40%) GN being 0, 5 (4-7), and 15 (10-31) days, respectively. The most common predisposing organism was Streptococcus pyogenes (137 of 353, 39%). Drug-resistant nonstreptococcal bacteria were methicillin-resistant Staphylococcus aureus (25%, four of 16), extended-spectrum β-lactamases (20%, 12 of 59), and carbapenem-resistant organisms (10%, six of 59). Twenty of 22 (91%) of the drug-resistant organisms were isolated from the parainfectious group. The most common site of infection was skin in peri- (23 of 97, 24%) and postinfectious GN (61 of 141, 43%), and urinary tract in parainfectious GN (35 of 115, 30%). Of 321 patients with >3 months of follow-up, 48 (15%) developed kidney failure over a median period of 10 (2-37) months and 14 (4%) died. Parainfectious GN, eGFR<30 ml/min per 1.73 m2, moderate-to-severe interstitial fibrosis and tubular atrophy, and nontreatment with renin-angiotensin system blockers were significant risk factors for progression to kidney failure by a Cox proportional-hazards model. CONCLUSIONS: Along with clinical and histologic predictors, parainfectious GN caused predominantly by nonstreptococcal and drug-resistant bacterial infections was associated with poor kidney prognosis.
引用
- John EE, Thomas A, Eapen JJ, et al. Latency, Anti-Bacterial Resistance Pattern, and Bacterial Infection-Related Glomerulonephritis. Clin J Am Soc Nephrol. 2021. PMID: 34099500. doi:10.2215/CJN.18631120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。